@article{Lane_J-2020_6938,
title = {Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study},
author = {Lane, J. and Weaver, J. and Kostka, K. and Duarte-Salles, T. and Abrahão, M. and Alghoul, H. and Alser, O. and Alshammari, T. and Biedermann, P. and Banda, J. and Burn, E. and Casajust, P. and Conover, M. and Culhane, A. and Davydov, A. and DuVall, S. and Dymshyts, D. and Fernández-Bertolín, S. and Fišter, K. and Hardin, J. and Hester, L. and Hripcsak, G. and Kaas-Hansen, B. and Kent, S. and Khosla, S. and Kolovos, S. and Lambert, C. and van der Lei, J. and Lynch, K. and Makadia, R. and Margulis, A. and Matheny, M. and Mehta, P. and Morales, D. and Morgan-Stewart, H. and Mosseveld, M. and Newby, D. and Nyberg, F. and Ostropolets, A. and Park, R. and Prats-Uribe, A. and Rao, G. and Reich, C. and Reps, J. and Rijnbeek, P. and Sathappan, S. and Schuemie, M. and Seager, S. and Sena, A. and Shoaibi, A. and Spotnitz, M. and Suchard, M. and Torre, C. and Vizcaya, D. and Wen, H. and de Wilde, M. and Xie, J. and You, S. and Zhang, L. and Zhuk, O. and Ryan, P. and Prieto-Alhambra, D.},
month = {aug},
year = {2020},
abstract = {Background: Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients with COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromycin, to determine the risk associated with its use in routine care in patients with rheumatoid arthritis.},
pages = {E698-E711},
volume = {2},
issue = {11},
journal = {The Lancet Rheumatology},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2665-9913(20)30276-9},
}
